Billings Clinic
Especially For:

Clinical Trials

Title   GI-Second Line Advanced Gastric or Gastroesophageal
Description   A Phase II Study of MK-2206 (NSC-749607) as Second Line Therapy for Advanced gastric and Gastroesophageal Junction Cancer
IRB Number   SWOG S1005
Category   Gastrointestinal
Inclusion/Notes   1. Patients must have histologically or cytologically confirmed adenocarcinoma of the stomach or GE junction that has progressed following 1st line therapy.
2. Must have measureable disease.


Please contact Tricia Montgomery, RN for further inclusion/exclusion criteria.
Status   Open
Start Date   02/11/2011
Principal Investigator (PI)   Jorge Nieva, MD
Contact Name   Tricia Montgomery, RN
Contact Email   tmontgomery@billingsclinic.org
Phone   (406) 435-7483
Fax   (406) 435-7489
Print This Page
Email to a Friend
Home | Contact | Site Map | Site Privacy Policy | Terms & Conditions | Patient Privacy Policy | Medical Records | Fast Command
2800 10th Ave. North | P.O. Box 37000 | Billings, Montana 59107 | 406.238.2500
© Copyright 2014 Billings Clinic. All Rights Reserved.